Home Healthcare Pharmaceuticals mRNA Therapeutics Market

mRNA Therapeutics Market Size, Share & Trends Analysis Report By Type (Prophylactic, Therapeutic), By Application (Oncology, Infectious Diseases, Rare Genetic Diseases, Others), By End User (Hospitals & Clinics, Research Organization, Others) and By Country (U.S., Canada) Forecasts, 2026-2034

Last Updated: July 13, 2026 | Author: Dhanashri B | Format: | Report Code: SR8045DR | Pages: 205
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. mRNA Therapeutics Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Prophylactic
    2. Therapeutic
  2. mRNA Therapeutics Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Oncology
    2. Infectious Diseases
    3. Rare Genetic Diseases
    4. Others
  3. mRNA Therapeutics Market, By End User 2022-2034 (USD MILLION/ Units)
    1. Hospitals & Clinics
    2. Research Organization
    3. Others
  4. Regional mRNA Therapeutics Market
    1. North America
      1. North America mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Prophylactic
        2. Therapeutic
      2. North America mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Rare Genetic Diseases
        4. Others
      3. North America mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Organization
        3. Others
      4. U.S.
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
      5. Canada
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
    2. Europe
      1. Europe mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Prophylactic
        2. Therapeutic
      2. Europe mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Rare Genetic Diseases
        4. Others
      3. Europe mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Organization
        3. Others
      4. U.K.
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
      5. Germany
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
      6. France
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
      7. Spain
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
      8. Italy
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
      9. Russia
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
      10. Nordic
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
      11. Benelux
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
      12. Rest of Europe
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
    3. APAC
      1. APAC mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Prophylactic
        2. Therapeutic
      2. APAC mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Rare Genetic Diseases
        4. Others
      3. APAC mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Organization
        3. Others
      4. China
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
      5. Korea
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
      6. Japan
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
      7. India
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
      8. Australia
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
      9. Taiwan
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
      10. South East Asia
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
      11. Rest of Asia-Pacific
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
    4. Middle East and Africa
      1. Middle East and Africa mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Prophylactic
        2. Therapeutic
      2. Middle East and Africa mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Rare Genetic Diseases
        4. Others
      3. Middle East and Africa mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Organization
        3. Others
      4. UAE
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
      5. Turkey
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
      6. Saudi Arabia
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
      7. South Africa
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
      8. Egypt
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
      9. Nigeria
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
      10. Rest of MEA
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
    5. LATAM
      1. LATAM mRNA Therapeutics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Prophylactic
        2. Therapeutic
      2. LATAM mRNA Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Infectious Diseases
        3. Rare Genetic Diseases
        4. Others
      3. LATAM mRNA Therapeutics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Research Organization
        3. Others
      4. Brazil
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
      5. Mexico
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
      6. Argentina
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
      7. Chile
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
      8. Colombia
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
      9. Rest of LATAM
        1. Prophylactic
        2. Therapeutic
        3. Oncology
        4. Infectious Diseases
        5. Rare Genetic Diseases
        6. Others
        7. Hospitals & Clinics
        8. Research Organization
        9. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.